Marvin, an AI agent from FutureHouse, scored 99/100 on Genentech's CompBioBench computational biology benchmark, with Marvin Lite scoring 95/100, outperforming GPT-5.6 Sol xhigh entries. The results h…
Anthropic is previewing the Model Hardware Standard (MHS), an interface that lets AI agents such as Claude operate lab equipment, robots, and factory systems, aiming to reduce hardware integration tim…
Anthropic introduced the Model Hardware Standard (MHS), a research preview interface that lets AI agents control physical machines such as lab instruments and robotic arms, aiming to reduce integratio…
Anthropic on Thursday proposed the Model Hardware Standard (MHS), a protocol for connecting AI agents to physical devices such as laboratory equipment and robots, with a research preview underway at H…
Anthropic introduced the Model Hardware Standard (MHS) on August 27, a software specification enabling AI agents like Claude to discover and control physical devices, from robotic arms to lab equipmen…
Anthropic released a research preview of the Model Hardware Standard (MHS), an extension of the Model Context Protocol (MCP) that lets AI agents control physical devices such as robotic arms and lab i…
Anthropic has launched a research preview of the Model Hardware Standard (MHS), an open standard designed to give AI agents a unified interface for controlling physical lab and manufacturing equipment…
Anthropic has introduced a Model Hardware Standard (MHS) research preview to help AI agents operate physical laboratory and industrial equipment, with early pilots at Genentech, HHMI Janelia, and QuEr…
A developer proposes a 'literature-in-the-loop' approach for AI-driven protein and antibody design, addressing the gap between the tens of thousands of candidates generated per cycle and the few hundr…
Phylo, Inc. announced on August 4, 2026 that Chugai Pharmaceutical Co., Ltd. will deploy Biomni Lab, Phylo's agentic AI platform for biomedical research, across Chugai's drug discovery workflows in si…
Roche's divarasib beat Amgen's Lumakras and Bristol Myers Squibb's Krazati in a head-to-head Phase 3 trial for KRAS G12C non-small cell lung cancer, showing statistically significant improvements in p…
Anthropic CEO Dario Amodei tempered expectations for AI-driven scientific breakthroughs at the company's 'The Briefing: AI for Science' event, suggesting the 'compressed 21st century' he predicted mig…
Nvidia and Genentech executives made the case for AI-driven drug discovery at BIO2026, highlighting their partnership that combines Genentech's biological data with Nvidia's computing infrastructure. …